Patent · US Active

Nanoparticles for treatment of allergy

US9597385B2 · kind B2 · utility

3Cited by
99References
7Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 23, 2013
Grant dateMar 21, 2017
Priority date
Expiry dateApr 23, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/6093
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention encompasses the surprising finding that nanoparticle compositions can have beneficial effects on allergy even when prepared without a known specific allergy therapeutic. The present invention provides such nanoparticle compositions. In some embodiments, provided nanoparticles are associated with functional elements that cause the nanoparticles to mimic bacterial cells. The present invention encompasses the surprising finding that provided nanoparticles may be useful for treatment and/or prevention of multiple different allergies in a single patient. The present invention encompasses the recognition that provided empty nanoparticles may be useful as a “pan-allergy” therapeutic and/or vaccine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.